About
Retatrutide is an investigational compound studied for body weight, appetite, and metabolic regulation.
Key facts
- Investigational triple receptor agonist
- Targets GIP, GLP-1, and glucagon receptors
- Positioned within obesity and metabolic research literature
More product information
This 20 mg format is the smaller Retatrutide strength. It targets GLP-1, GIP, and glucagon pathways, which gives it a broader metabolic profile than single-pathway compounds.
- Cellular & Metabolic category
- Investigational single-compound listing
- Documentation support available on request
- Use the strength selector to compare the 20 mg and 60 mg formats
